Sign In
Buy RIVN
$17.24
-0.215 (-1.23%)
At Close: Jul 20, 2026
Rivian vs. Ford: The Underdog Story Investors Should Be Watching
09:46am, Wednesday, 08'th Apr 2026
Rivian generates significantly less revenue than Ford, but both companies are posting losses, which makes the path to profitability more important than top-line size. Investors should watch whether Ri
2 Stocks With Monster Potential to Hold Through the Next Decade of Chaos
09:05am, Wednesday, 08'th Apr 2026
AI is upending countless industries. Rivian and Oklo, in particular, have monster upside potential.
Rivian Automotive (RIVN) Stock Dips While Market Gains: Key Facts
06:51pm, Tuesday, 07'th Apr 2026
In the closing of the recent trading day, Rivian Automotive (RIVN) stood at $14.69, denoting a -3.92% move from the preceding trading day.
Rivian Beats on Q1 Delivery Estimates Ahead of R2 Launch
03:36pm, Tuesday, 07'th Apr 2026
Rivian beats Q1 delivery estimates, reaffirms 2026 outlook, and gears up for lower-priced R2 launch.
Rivian Tumbles 5% After U.S. Sales Plunge 26%, With R2 Launch and April 30 Earnings in Focus
03:18pm, Tuesday, 07'th Apr 2026
Rivian Automotive (NASDAQ:RIVN | RIVN Price Prediction) shares are sliding 5% today, moving from $15.29 to around $14.50, as investors react to a steep drop in U.S.
Spring Cleaning Your Portfolio: 4 Stocks With Rising Risks Heading Into Q2
11:05am, Tuesday, 07'th Apr 2026
High expectations for artificial intelligence growth remain a potential risk, as market valuations for leading technology companies appear overextended.
ReElement Technologies sets April conference schedule
05:21am, Monday, 06'th Apr 2026
ReElement Technologies, backed by American Resources Corp (NASDAQ:AREC), will attend several April events to advance discussions on critical minerals and...
Highland Critical Minerals completes private placement
04:58am, Monday, 06'th Apr 2026
Highland Critical Minerals Corp (CSE:HLND, FRA:U8X) announced it has completed a non-brokered flow-through private placement, raising gross proceeds of...
Medicus Pharma submits optimized Phase 2 Teverelix trial protocol to FDA
04:38am, Monday, 06'th Apr 2026
Medicus Pharma (NASDAQ:MDCX) announced on Monday that it has submitted an optimized Phase 2 clinical study protocol to the US Food and Drug Administration...
Medicus Pharma SkinJect Phase 2 study data endorsed by independent expert - ICYMI
06:00am, Saturday, 04'th Apr 2026
Medicus Pharma (NASDAQ:MDCX) earlier this week outlined further progress in its Skinject program following the release of Phase 2 topline data, alongside...
Purepoint Uranium CEO discusses exploration strategy at Dorado project - ICYMI
04:00am, Saturday, 04'th Apr 2026
Purepoint Uranium Group Inc (TSX-V:PTU, OTCQX:PTUUF, FRA:P5X0) CEO Chris Frostad talked with Proactive about the company’s latest uranium exploration...
Rivian Just Earned Another $1 Billion Investment From Volkswagen. Here's Why That's An Important Milestone for the Stock.
04:15pm, Friday, 03'rd Apr 2026
Rivian is taking a multi-prong approach to growing its business. The company's relationship with Volkswagen is important in two ways.
1 Reason to Buy Rivian Like There's No Tomorrow. Hint: It's Not the R2
11:15am, Friday, 03'rd Apr 2026
Investors focusing on Rivian's R2 launch might be missing the bigger picture. Rivian's partnerships with Uber and Volkswagen could be a sign of things to come.
First Phosphats wraps up 40,000-meter drill program at Bégin-Lamarche - ICYMI
06:00am, Friday, 03'rd Apr 2026
First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF, FRA:KD0, OTC:FPHOY) CEO John Passalacqua talked with Proactive about the completion of the company’s...
Accesso, Light Science Technologies, Poolbeg Pharma, Digitalbox, RC Fornax, Gaming Realms
05:00am, Friday, 03'rd Apr 2026
Accesso Technology Group PLC (LSE:ACSO, OTC:LOQPF, FRA:LQG) CEO Steve Brown says the acquisition of Dexibit is a step change in how the company delivers...
